The Market Reports

Index

1 MRD (Minimal Residual Disease) Testing Market Overview
1.1 Product Overview and Scope of MRD (Minimal Residual Disease) Testing
1.2 MRD (Minimal Residual Disease) Testing Segment by Type
1.2.1 Global MRD (Minimal Residual Disease) Testing Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Flow Cytometry
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Next-Generation Sequencing (NGS)
1.3 MRD (Minimal Residual Disease) Testing Segment by Application
1.3.1 Global MRD (Minimal Residual Disease) Testing Sales Comparison by Application: (2021-2027)
1.3.2 Specialty Clinics and Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research Institutions
1.4 Global MRD (Minimal Residual Disease) Testing Market Size Estimates and Forecasts
1.4.1 Global MRD (Minimal Residual Disease) Testing Revenue 2016-2027
1.4.2 Global MRD (Minimal Residual Disease) Testing Sales 2016-2027
1.4.3 MRD (Minimal Residual Disease) Testing Market Size by Region: 2016 Versus 2021 Versus 2027

2 MRD (Minimal Residual Disease) Testing Market Competition by Manufacturers
2.1 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Manufacturers (2016-2021)
2.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Manufacturers (2016-2021)
2.3 Global MRD (Minimal Residual Disease) Testing Average Price by Manufacturers (2016-2021)
2.4 Manufacturers MRD (Minimal Residual Disease) Testing Manufacturing Sites, Area Served, Product Type
2.5 MRD (Minimal Residual Disease) Testing Market Competitive Situation and Trends
2.5.1 MRD (Minimal Residual Disease) Testing Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest MRD (Minimal Residual Disease) Testing Players Market Share by Revenue
2.5.3 Global MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 MRD (Minimal Residual Disease) Testing Retrospective Market Scenario by Region
3.1 Global MRD (Minimal Residual Disease) Testing Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global MRD (Minimal Residual Disease) Testing Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America MRD (Minimal Residual Disease) Testing Market Facts & Figures by Country
3.3.1 North America MRD (Minimal Residual Disease) Testing Sales by Country
3.3.2 North America MRD (Minimal Residual Disease) Testing Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe MRD (Minimal Residual Disease) Testing Market Facts & Figures by Country
3.4.1 Europe MRD (Minimal Residual Disease) Testing Sales by Country
3.4.2 Europe MRD (Minimal Residual Disease) Testing Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific MRD (Minimal Residual Disease) Testing Market Facts & Figures by Region
3.5.1 Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region
3.5.2 Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America MRD (Minimal Residual Disease) Testing Market Facts & Figures by Country
3.6.1 Latin America MRD (Minimal Residual Disease) Testing Sales by Country
3.6.2 Latin America MRD (Minimal Residual Disease) Testing Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa MRD (Minimal Residual Disease) Testing Market Facts & Figures by Country
3.7.1 Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Country
3.7.2 Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global MRD (Minimal Residual Disease) Testing Historic Market Analysis by Type
4.1 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
4.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2016-2021)
4.3 Global MRD (Minimal Residual Disease) Testing Price by Type (2016-2021)

5 Global MRD (Minimal Residual Disease) Testing Historic Market Analysis by Application
5.1 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
5.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2016-2021)
5.3 Global MRD (Minimal Residual Disease) Testing Price by Application (2016-2021)

6 Key Companies Profiled
6.1 ICON plc
6.1.1 ICON plc Corporation Information
6.1.2 ICON plc Description and Business Overview
6.1.3 ICON plc MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.1.4 ICON plc MRD (Minimal Residual Disease) Testing Product Portfolio
6.1.5 ICON plc Recent Developments/Updates
6.2 ArcherDX(Invitae)
6.2.1 ArcherDX(Invitae) Corporation Information
6.2.2 ArcherDX(Invitae) Description and Business Overview
6.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.2.4 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Portfolio
6.2.5 ArcherDX(Invitae) Recent Developments/Updates
6.3 ARUP Laboratories
6.3.1 ARUP Laboratories Corporation Information
6.3.2 ARUP Laboratories Description and Business Overview
6.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.3.4 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Portfolio
6.3.5 ARUP Laboratories Recent Developments/Updates
6.4 Asuragen
6.4.1 Asuragen Corporation Information
6.4.2 Asuragen Description and Business Overview
6.4.3 Asuragen MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Asuragen MRD (Minimal Residual Disease) Testing Product Portfolio
6.4.5 Asuragen Recent Developments/Updates
6.5 Cergentis B.V.
6.5.1 Cergentis B.V. Corporation Information
6.5.2 Cergentis B.V. Description and Business Overview
6.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Portfolio
6.5.5 Cergentis B.V. Recent Developments/Updates
6.6 Bio-Rad Laboratories
6.6.1 Bio-Rad Laboratories Corporation Information
6.6.2 Bio-Rad Laboratories Description and Business Overview
6.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Portfolio
6.6.5 Bio-Rad Laboratories Recent Developments/Updates
6.7 Mission Bio
6.6.1 Mission Bio Corporation Information
6.6.2 Mission Bio Description and Business Overview
6.6.3 Mission Bio MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mission Bio MRD (Minimal Residual Disease) Testing Product Portfolio
6.7.5 Mission Bio Recent Developments/Updates
6.8 Guardant Health
6.8.1 Guardant Health Corporation Information
6.8.2 Guardant Health Description and Business Overview
6.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Guardant Health MRD (Minimal Residual Disease) Testing Product Portfolio
6.8.5 Guardant Health Recent Developments/Updates
6.9 Invivoscribe
6.9.1 Invivoscribe Corporation Information
6.9.2 Invivoscribe Description and Business Overview
6.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Invivoscribe MRD (Minimal Residual Disease) Testing Product Portfolio
6.9.5 Invivoscribe Recent Developments/Updates
6.10 LabCorp
6.10.1 LabCorp Corporation Information
6.10.2 LabCorp Description and Business Overview
6.10.3 LabCorp MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.10.4 LabCorp MRD (Minimal Residual Disease) Testing Product Portfolio
6.10.5 LabCorp Recent Developments/Updates
6.11 Inivata
6.11.1 Inivata Corporation Information
6.11.2 Inivata MRD (Minimal Residual Disease) Testing Description and Business Overview
6.11.3 Inivata MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Inivata MRD (Minimal Residual Disease) Testing Product Portfolio
6.11.5 Inivata Recent Developments/Updates
6.12 Natera
6.12.1 Natera Corporation Information
6.12.2 Natera MRD (Minimal Residual Disease) Testing Description and Business Overview
6.12.3 Natera MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Natera MRD (Minimal Residual Disease) Testing Product Portfolio
6.12.5 Natera Recent Developments/Updates
6.13 NeoGenomics Laboratories
6.13.1 NeoGenomics Laboratories Corporation Information
6.13.2 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Description and Business Overview
6.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.13.4 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Portfolio
6.13.5 NeoGenomics Laboratories Recent Developments/Updates
6.14 Opko Health
6.14.1 Opko Health Corporation Information
6.14.2 Opko Health MRD (Minimal Residual Disease) Testing Description and Business Overview
6.14.3 Opko Health MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Opko Health MRD (Minimal Residual Disease) Testing Product Portfolio
6.14.5 Opko Health Recent Developments/Updates
6.15 Quest Diagnostics
6.15.1 Quest Diagnostics Corporation Information
6.15.2 Quest Diagnostics MRD (Minimal Residual Disease) Testing Description and Business Overview
6.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Portfolio
6.15.5 Quest Diagnostics Recent Developments/Updates
6.16 Sysmex Corporation
6.16.1 Sysmex Corporation Corporation Information
6.16.2 Sysmex Corporation MRD (Minimal Residual Disease) Testing Description and Business Overview
6.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Portfolio
6.16.5 Sysmex Corporation Recent Developments/Updates
6.17 Adaptive Biotechnologies
6.17.1 Adaptive Biotechnologies Corporation Information
6.17.2 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Description and Business Overview
6.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Portfolio
6.17.5 Adaptive Biotechnologies Recent Developments/Updates

7 MRD (Minimal Residual Disease) Testing Manufacturing Cost Analysis
7.1 MRD (Minimal Residual Disease) Testing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of MRD (Minimal Residual Disease) Testing
7.4 MRD (Minimal Residual Disease) Testing Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 MRD (Minimal Residual Disease) Testing Distributors List
8.3 MRD (Minimal Residual Disease) Testing Customers

9 MRD (Minimal Residual Disease) Testing Market Dynamics
9.1 MRD (Minimal Residual Disease) Testing Industry Trends
9.2 MRD (Minimal Residual Disease) Testing Growth Drivers
9.3 MRD (Minimal Residual Disease) Testing Market Challenges
9.4 MRD (Minimal Residual Disease) Testing Market Restraints

10 Global Market Forecast
10.1 MRD (Minimal Residual Disease) Testing Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of MRD (Minimal Residual Disease) Testing by Type (2022-2027)
10.1.2 Global Forecasted Revenue of MRD (Minimal Residual Disease) Testing by Type (2022-2027)
10.2 MRD (Minimal Residual Disease) Testing Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of MRD (Minimal Residual Disease) Testing by Application (2022-2027)
10.2.2 Global Forecasted Revenue of MRD (Minimal Residual Disease) Testing by Application (2022-2027)
10.3 MRD (Minimal Residual Disease) Testing Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of MRD (Minimal Residual Disease) Testing by Region (2022-2027)
10.3.2 Global Forecasted Revenue of MRD (Minimal Residual Disease) Testing by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global MRD (Minimal Residual Disease) Testing Sales (Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global MRD (Minimal Residual Disease) Testing Sales (Units) Comparison by Application (2021-2027)
Table 3. Global MRD (Minimal Residual Disease) Testing Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers MRD (Minimal Residual Disease) Testing Covered in This Study
Table 5. Global MRD (Minimal Residual Disease) Testing Sales (Units) of Key Manufacturers (2016-2021)
Table 6. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Manufacturers (2016-2021)
Table 7. Global MRD (Minimal Residual Disease) Testing Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global MRD (Minimal Residual Disease) Testing Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market MRD (Minimal Residual Disease) Testing Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers MRD (Minimal Residual Disease) Testing Manufacturing Sites and Area Served
Table 11. Manufacturers MRD (Minimal Residual Disease) Testing Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global MRD (Minimal Residual Disease) Testing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in MRD (Minimal Residual Disease) Testing as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global MRD (Minimal Residual Disease) Testing Sales by Region (2016-2021) & (Units)
Table 16. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2016-2021)
Table 17. Global MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021) & (Units)
Table 19. North America MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2021)
Table 20. North America MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2021)
Table 22. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021) & (Units)
Table 23. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2021)
Table 24. Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific MRD (Minimal Residual Disease) Testing Sales by Region (2016-2021) & (Units)
Table 27. Asia Pacific MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2016-2021)
Table 30. Latin America MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021) & (Units)
Table 31. Latin America MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2021)
Table 32. Latin America MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021) & (Units)
Table 35. Middle East and Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2021)
Table 38. Global MRD (Minimal Residual Disease) Testing Sales (Units) by Type (2016-2021)
Table 39. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
Table 40. Global MRD (Minimal Residual Disease) Testing Revenue (Million US$) by Type (2016-2021)
Table 41. Global MRD (Minimal Residual Disease) Testing Revenue Share by Type (2016-2021)
Table 42. Global MRD (Minimal Residual Disease) Testing Price (US$/Unit) by Type (2016-2021)
Table 43. Global MRD (Minimal Residual Disease) Testing Sales (Units) by Application (2016-2021)
Table 44. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Table 45. Global MRD (Minimal Residual Disease) Testing Revenue (Million US$) by Application (2016-2021)
Table 46. Global MRD (Minimal Residual Disease) Testing Revenue Share by Application (2016-2021)
Table 47. Global MRD (Minimal Residual Disease) Testing Price (US$/Unit) by Application (2016-2021)
Table 48. ICON plc Corporation Information
Table 49. ICON plc Description and Business Overview
Table 50. ICON plc MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. ICON plc MRD (Minimal Residual Disease) Testing Product
Table 52. ICON plc Recent Developments/Updates
Table 53. ArcherDX(Invitae) Corporation Information
Table 54. ArcherDX(Invitae) Description and Business Overview
Table 55. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product
Table 57. ArcherDX(Invitae) Recent Developments/Updates
Table 58. ARUP Laboratories Corporation Information
Table 59. ARUP Laboratories Description and Business Overview
Table 60. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product
Table 62. ARUP Laboratories Recent Developments/Updates
Table 63. Asuragen Corporation Information
Table 64. Asuragen Description and Business Overview
Table 65. Asuragen MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Asuragen MRD (Minimal Residual Disease) Testing Product
Table 67. Asuragen Recent Developments/Updates
Table 68. Cergentis B.V. Corporation Information
Table 69. Cergentis B.V. Description and Business Overview
Table 70. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product
Table 72. Cergentis B.V. Recent Developments/Updates
Table 73. Bio-Rad Laboratories Corporation Information
Table 74. Bio-Rad Laboratories Description and Business Overview
Table 75. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product
Table 77. Bio-Rad Laboratories Recent Developments/Updates
Table 78. Mission Bio Corporation Information
Table 79. Mission Bio Description and Business Overview
Table 80. Mission Bio MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Mission Bio MRD (Minimal Residual Disease) Testing Product
Table 82. Mission Bio Recent Developments/Updates
Table 83. Guardant Health Corporation Information
Table 84. Guardant Health Description and Business Overview
Table 85. Guardant Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Guardant Health MRD (Minimal Residual Disease) Testing Product
Table 87. Guardant Health Recent Developments/Updates
Table 88. Invivoscribe Corporation Information
Table 89. Invivoscribe Description and Business Overview
Table 90. Invivoscribe MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Invivoscribe MRD (Minimal Residual Disease) Testing Product
Table 92. Invivoscribe Recent Developments/Updates
Table 93. LabCorp Corporation Information
Table 94. LabCorp Description and Business Overview
Table 95. LabCorp MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. LabCorp MRD (Minimal Residual Disease) Testing Product
Table 97. LabCorp Recent Developments/Updates
Table 98. Inivata Corporation Information
Table 99. Inivata Description and Business Overview
Table 100. Inivata MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Inivata MRD (Minimal Residual Disease) Testing Product
Table 102. Inivata Recent Developments/Updates
Table 103. Natera Corporation Information
Table 104. Natera Description and Business Overview
Table 105. Natera MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Natera MRD (Minimal Residual Disease) Testing Product
Table 107. Natera Recent Developments/Updates
Table 108. NeoGenomics Laboratories Corporation Information
Table 109. NeoGenomics Laboratories Description and Business Overview
Table 110. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product
Table 112. NeoGenomics Laboratories Recent Developments/Updates
Table 113. Opko Health Corporation Information
Table 114. Opko Health Description and Business Overview
Table 115. Opko Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Opko Health MRD (Minimal Residual Disease) Testing Product
Table 117. Opko Health Recent Developments/Updates
Table 118. Quest Diagnostics Corporation Information
Table 119. Quest Diagnostics Description and Business Overview
Table 120. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product
Table 122. Quest Diagnostics Recent Developments/Updates
Table 123. Sysmex Corporation Corporation Information
Table 124. Sysmex Corporation Description and Business Overview
Table 125. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product
Table 127. Sysmex Corporation Recent Developments/Updates
Table 128. Adaptive Biotechnologies Corporation Information
Table 129. Adaptive Biotechnologies Description and Business Overview
Table 130. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product
Table 132. Adaptive Biotechnologies Recent Developments/Updates
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. MRD (Minimal Residual Disease) Testing Distributors List
Table 136. MRD (Minimal Residual Disease) Testing Customers List
Table 137. MRD (Minimal Residual Disease) Testing Market Trends
Table 138. MRD (Minimal Residual Disease) Testing Growth Drivers
Table 139. MRD (Minimal Residual Disease) Testing Market Challenges
Table 140. MRD (Minimal Residual Disease) Testing Market Restraints
Table 141. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Type (2022-2027) & (Units)
Table 142. Global MRD (Minimal Residual Disease) Testing Sales Market Share Forecast by Type (2022-2027)
Table 143. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 144. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Type (2022-2027)
Table 145. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Application (2022-2027) & (Units)
Table 146. Global MRD (Minimal Residual Disease) Testing Sales Market Share Forecast by Application (2022-2027)
Table 147. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 148. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Application (2022-2027)
Table 149. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Region (2022-2027) & (Units)
Table 150. Global MRD (Minimal Residual Disease) Testing Sales Market Share Forecast by Region (2022-2027)
Table 151. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 152. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Region (2022-2027)
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of MRD (Minimal Residual Disease) Testing
Figure 2. Global MRD (Minimal Residual Disease) Testing Market Share by Type in 2020 & 2027
Figure 3. Flow Cytometry Product Picture
Figure 4. Polymerase Chain Reaction (PCR) Product Picture
Figure 5. Next-Generation Sequencing (NGS) Product Picture
Figure 6. Global MRD (Minimal Residual Disease) Testing Market Share by Application in 2020 & 2027
Figure 7. Specialty Clinics and Hospitals
Figure 8. Diagnostic Laboratories
Figure 9. Research Institutions
Figure 10. Global MRD (Minimal Residual Disease) Testing Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global MRD (Minimal Residual Disease) Testing Market Size 2016-2027 (US$ Million)
Figure 12. Global MRD (Minimal Residual Disease) Testing Sales 2016-2027 (Units)
Figure 13. Global MRD (Minimal Residual Disease) Testing Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. MRD (Minimal Residual Disease) Testing Sales Share by Manufacturers in 2020
Figure 15. Global MRD (Minimal Residual Disease) Testing Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest MRD (Minimal Residual Disease) Testing Players: Market Share by Revenue in 2020
Figure 17. MRD (Minimal Residual Disease) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2016-2021)
Figure 19. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region in 2020
Figure 20. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2016-2021)
Figure 21. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region in 2020
Figure 22. U.S. MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE MRD (Minimal Residual Disease) Testing Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of MRD (Minimal Residual Disease) Testing by Type (2016-2021)
Figure 47. Sales Market Share of MRD (Minimal Residual Disease) Testing by Application (2016-2021)
Figure 48. Sales Market Share of MRD (Minimal Residual Disease) Testing by Application in 2020
Figure 49. Revenue Share of MRD (Minimal Residual Disease) Testing by Application (2016-2021)
Figure 50. Revenue Share of MRD (Minimal Residual Disease) Testing by Application in 2020
Figure 51. Manufacturing Cost Structure of MRD (Minimal Residual Disease) Testing
Figure 52. Manufacturing Process Analysis of MRD (Minimal Residual Disease) Testing
Figure 53. MRD (Minimal Residual Disease) Testing Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed